Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.
Saved in:
| Title: | Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial. |
|---|---|
| Authors: | Kimball AB; Harvard Medical School and Clinical Laboratory for Epidemiology and Applied Research in Skin, Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Sawicki KT; AbbVie Inc, North Chicago, Illinois., Ackerman L; Medical Dermatology Specialists, US Dermatology Partners, University of Arizona College of Medicine, Phoenix., Lima H; LEADER Research, Medicine Department Division of Clinical Immunology and Allergy, Division of Dermatology, McMaster University, Hamilton, Ontario, Canada., Giamarellos-Bourboulis EJ; Fourth Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Zhan T; AbbVie Inc, North Chicago, Illinois., Drogaris L; AbbVie Inc, North Chicago, Illinois., Gu Y; AbbVie Inc, North Chicago, Illinois., Lee CM; AbbVie Inc, North Chicago, Illinois., Akbari M; AbbVie Inc, North Chicago, Illinois., Williams DA; AbbVie Inc, North Chicago, Illinois., Bechara FG; International Center for Hidradenitis Suppurativa/Acne Inversa, Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, Germany. |
| Source: | JAMA dermatology [JAMA Dermatol] 2026 May 01; Vol. 162 (5), pp. 469-477. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6084 |
|---|---|
| DOI: | 10.1001/jamadermatol.2026.0155 |
